- Home
- SXTP vs ACON Comparison
SXTP vs ACON Comparison
Compare SXTP & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXTP
- ACON
- Stock Information
- Founded
- SXTP 2010
- ACON 2008
- Country
- SXTP United States
- ACON United States
- Employees
- SXTP N/A
- ACON N/A
- Industry
- SXTP Biotechnology: Pharmaceutical Preparations
- ACON Retail: Computer Software & Peripheral Equipment
- Sector
- SXTP Health Care
- ACON Technology
- Exchange
- SXTP Nasdaq
- ACON Nasdaq
- Market Cap
- SXTP 1.6M
- ACON 1.7M
- IPO Year
- SXTP 2023
- ACON 2022
- Fundamental
- Price
- SXTP $1.38
- ACON $0.11
- Analyst Decision
- SXTP Hold
- ACON Buy
- Analyst Count
- SXTP 1
- ACON 2
- Target Price
- SXTP N/A
- ACON $1.30
- AVG Volume (30 Days)
- SXTP 712.1K
- ACON 991.9K
- Earning Date
- SXTP 11-14-2024
- ACON 11-14-2024
- Dividend Yield
- SXTP N/A
- ACON N/A
- EPS Growth
- SXTP N/A
- ACON N/A
- EPS
- SXTP N/A
- ACON N/A
- Revenue
- SXTP $462,612.00
- ACON $49,289.00
- Revenue This Year
- SXTP $267.05
- ACON N/A
- Revenue Next Year
- SXTP $181.82
- ACON $186.36
- P/E Ratio
- SXTP N/A
- ACON N/A
- Revenue Growth
- SXTP 128.99
- ACON N/A
- 52 Week Low
- SXTP $0.70
- ACON $0.10
- 52 Week High
- SXTP $18.36
- ACON $7.39
- Technical
- Relative Strength Index (RSI)
- SXTP 52.58
- ACON 30.75
- Support Level
- SXTP $1.35
- ACON $0.16
- Resistance Level
- SXTP $1.74
- ACON $0.20
- Average True Range (ATR)
- SXTP 0.28
- ACON 0.02
- MACD
- SXTP 0.01
- ACON -0.01
- Stochastic Oscillator
- SXTP 26.00
- ACON 13.37
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The Company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.